Bevacizumab: no comeback in early breast cancer?
Department of Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria. Electronic address: rupert.bartsch@meduniwien.ac.at.
Rupert
R
Bartsch
Department of Surgery, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
Michael
M
Gnant
Department of Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
Guenther G
GG
Steger
D000068258:Bevacizumab / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
D000068258:Bevacizumab